Related Experiment Video
Updated: Dec 2, 2025

06:49
Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
2.4K
[Pathological Complete Response in Multiple Advanced Rectal Cancers with Neoadjuvant CapeOX plus BV Therapy-A Case
Komei Kuge1, Akihisa Matsuda, Takeaki Fujihira
1Dept. of Surgery, Kuriyama Central Hospital.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|November 1, 2020
Summary
Neoadjuvant chemotherapy with capecitabine, oxaliplatin, and bevacizumab (CapeOX plus BV) shows promise for advanced rectal cancer. This treatment led to significant tumor reduction and a pathological complete response in one patient.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Locally advanced rectal cancer presents significant treatment challenges.
- Neoadjuvant therapy aims to downstage tumors and improve surgical outcomes.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Targeted Cancer Therapies
8.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.2K

